Document is current
Any future updates will be listed below
-
Authors
Hu, Marie https://orcid.org/0000-0002-9847-7207
Goyal, Gaurav https://orcid.org/0000-0001-6148-5177
Abeykoon, Jithma P. https://orcid.org/0000-0003-3939-6252
Acosta-Medina, Aldo A. https://orcid.org/0000-0001-9414-9153
Ruan, Gordan J.
Young, Jason R. https://orcid.org/0000-0001-5351-8266
Ravindran, Aishwarya
Bennani, N. Nora https://orcid.org/0000-0001-8358-5953
Shah, Mithun V. https://orcid.org/0000-0002-5359-336X
Vassallo, Robert
Ryu, Jay H. https://orcid.org/0000-0002-9576-2272
Davidge-Pitts, Caroline J.
Koster, Matthew J.
Tobin, W. Oliver https://orcid.org/0000-0002-8141-2394
Sartori-Valinotti, Julio C.
Rech, Karen L.
Go, Ronald S. https://orcid.org/0000-0002-8284-3495
- License Information
-
More Information
Article History
Received: 9 November 2021
Revised: 18 April 2022
Accepted: 25 May 2022
First Online: 3 June 2022
Competing interests
: MH, GG, JA, AAA, GJR, JRY, AR, NNB, MVS, JHR, CJD, MJK, WOT, JCS, KLR, RSG—none. RV—research funding from Pfizer, Bristol Myers Squibb, and Sun Pharmaceuticals. is available at <i>Blood Cancer Journal’s</i> website.
